Johnson & Johnson (JNJ)
263.81
-3.80
(-1.42%)
USD |
NYSE |
Oct 23, 16:00
263.85
+0.04
(+0.02%)
Pre-Market: 20:00
Johnson & Johnson Price to Book Value : 7.789 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.789 |
| October 22, 2026 | 7.901 |
| October 21, 2026 | 7.611 |
| October 20, 2026 | 7.658 |
| October 19, 2026 | 7.493 |
| October 16, 2026 | 7.545 |
| October 15, 2026 | 7.478 |
| October 14, 2026 | 7.497 |
| October 13, 2026 | 7.340 |
| October 12, 2026 | 7.786 |
| October 09, 2026 | 7.719 |
| October 08, 2026 | 7.572 |
| October 07, 2026 | 7.631 |
| October 06, 2026 | 7.522 |
| October 05, 2026 | 7.468 |
| October 02, 2026 | 7.559 |
| October 01, 2026 | 7.637 |
| September 30, 2026 | 7.816 |
| September 29, 2026 | 7.583 |
| September 28, 2026 | 7.708 |
| September 25, 2026 | 7.687 |
| September 24, 2026 | 7.672 |
| September 23, 2026 | 7.629 |
| September 22, 2026 | 7.629 |
| September 21, 2026 | 7.637 |
| Date | Value |
|---|---|
| September 18, 2026 | 7.652 |
| September 17, 2026 | 7.658 |
| September 16, 2026 | 7.575 |
| September 15, 2026 | 7.573 |
| September 14, 2026 | 7.548 |
| September 11, 2026 | 7.527 |
| September 10, 2026 | 7.549 |
| September 09, 2026 | 7.570 |
| September 08, 2026 | 7.627 |
| September 04, 2026 | 7.800 |
| September 03, 2026 | 7.891 |
| September 02, 2026 | 7.800 |
| September 01, 2026 | 7.686 |
| August 31, 2026 | 7.535 |
| August 28, 2026 | 7.597 |
| August 27, 2026 | 7.532 |
| August 26, 2026 | 7.652 |
| August 25, 2026 | 7.741 |
| August 24, 2026 | 7.738 |
| August 21, 2026 | 7.659 |
| August 20, 2026 | 7.578 |
| August 19, 2026 | 7.749 |
| August 18, 2026 | 7.684 |
| August 17, 2026 | 7.436 |
| August 14, 2026 | 7.379 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 35.39 |
| Merck & Co., Inc. | 8.552 |
| Pfizer Inc. | 2.009 |
| Bristol Myers Squibb Co. | 5.628 |
| Abbott Laboratories | 3.511 |
Price to Book Value Related Metrics
| PE Ratio | 40.02 |
| PS Ratio | 6.488 |
| Price to Free Cash Flow | 32.26 |
| Price | 263.81 |
| Earnings Yield | 2.50% |
| Market Cap | 635.02B |
| Operating PE Ratio | 25.10 |
| Normalized PE Ratio | 28.45 |